Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

Elevated serum levels of soluble interleukin 2 receptor, interleukin 2 and neopterin in diffuse and limited scleroderma: effects of chlorambucil.

Authors: Clements, PJ  Peter, JB  Agopian, MS  Telian, NS  Furst, DE 
Citation: Clements PJ, etal., J Rheumatol. 1990 Jul;17(7):908-10.
Pubmed: (View Article at PubMed) PMID:2213757

In a study of 48 patients with systemic sclerosis (SSc). elevated serum levels of soluble interleukin 2 receptor (IL-2R), interleukin 2 (IL-2) and neopterin (indicators of lymphocyte/monocyte activation) were noted in 100, 44 and 40% of early untreated patients with SSc (11 diffuse, 5 Limited). Levels of IL-2R, but not IL-2 or neopterin, were lower in patients with longer duration of disease and possibly with chlorambucil therapy. Pharmacologic alterations of markers of humoral or cell mediated immunity may not be an accurate reflection of clinical efficacy of chlorambucil.


Disease Annotations
Objects Annotated

Additional Information

CRRD Object Information
CRRD ID: 8663482
Created: 2014-07-03
Species: All species
Last Modified: 2014-07-03
Status: ACTIVE


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.